Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

ClinicalTrials.gov ID: NCT01145859

Public ClinicalTrials.gov record NCT01145859. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 2:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Single-dose Pilot Study of Oral Rivaroxaban in Pediatric Subjects With Venous Thromboembolism

Study identification

NCT ID: NCT01145859
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Bayer; Industry
Enrollment: 59 participants

Conditions and interventions

Conditions

Interventions

Rivaroxaban (Xarelto, BAY59-7939) Drug

Drug

Eligibility (public fields only)

Age range: 6 Months to 18 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2010
Primary completion: Jun 30, 2015
Completion: Jun 30, 2015
Last update posted: Aug 5, 2015

2010 – 2015

United States locations

U.S. sites: 16
U.S. states: 10
U.S. cities: 14

Facility	City	State	ZIP	Site status
Not listed	Little Rock	Arkansas	72202-3500	—
Not listed	Los Angeles	California	90027-6089	—
Not listed	Los Angeles	California	90095	—
Not listed	Orange	California	92868	—
Not listed	Gainesville	Florida	32610	—
Not listed	St. Petersburg	Florida	33701	—
Not listed	Chicago	Illinois	60611	—
Not listed	Indianapolis	Indiana	46202	—
Not listed	Indianapolis	Indiana	46260	—
Not listed	Detroit	Michigan	48201-2196	—
Not listed	New Hyde Park	New York	11040	—
Not listed	Chapel Hill	North Carolina	27514	—
Not listed	Durham	North Carolina	27710	—
Not listed	Cleveland	Ohio	44106-6007	—
Not listed	Philadelphia	Pennsylvania	19104	—
Not listed	Pittsburgh	Pennsylvania	15224	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01145859, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 5, 2015 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01145859 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →